Clinical Trial Update: Phase III Confirmatory Study in Erythropoietic Protoporphyria [Phase 3]

View source ↗

Summary

Phase III confirmatory study in erythropoietic protoporphyria completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria

Drugs mentioned

• Clinuvel Pharmaceuticals Limited

Snippet

Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Erythropoietic Protoporphyria | Phase 3 | Status: COMPLETED | Results posted: 2019-08-26